<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Investigators in other countries have observed that the neutralizing antibody titre in sick infants and their mothers were generally lower than healthy controls
 <sup>
  <xref ref-type="bibr" rid="CR24">24</xref>
 </sup>, and that maternal antibody titres were lower in mothers in their 30’s and 40’s than younger mothers
 <sup>
  <xref ref-type="bibr" rid="CR25">25</xref>
 </sup>. In 2017, the median age of mothers in Australia was 30.7 years (Australian Bureau of Statistics, 2017 
 <ext-link ext-link-type="uri" xlink:href="http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3301.02010?OpenDocument" xmlns:xlink="http://www.w3.org/1999/xlink">http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/3301.02010?OpenDocument</ext-link>). An age associated decrease in neutralizing antibody titres has been observed in the Australian population in people aged over 30 years
 <sup>
  <xref ref-type="bibr" rid="CR12">12</xref>
 </sup>, and therefore the majority of babies born in Australia may continue to have little protection against HPeV3 during the first 3 months of life when infection, for reasons not yet known, is most problematic.
</p>
